References
-
1
Bortolato M, Frau R, Orru M. et al .
Antipsychotic-like properties of 5-α-reductase inhibitors.
Neuropsychopharmacology.
2007;
in press
-
2
Cabrera RJ, Bregonzio C, Laconi M, Mampel A.
Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3 H]dopamine release is estrogen and progesterone dependent.
Cell Mol Neurobiol.
2002;
22
445-454
-
3
Carlsson A.
The neurochemical circuitry of schizophrenia.
Pharmacopsychiatry.
2006;
39
((Suppl 1))
S10-14
-
4
Hernandez L, Gonzalez L, Murzi E. et al .
Testosterone modulates mesolimbic dopaminergic activity in male rats.
Neurosci Lett.
1994;
171
172-174
-
5
Khisti RT, Deshpande LS, Chopde CT.
The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Psychopharmacology (Berl).
2002;
161
120-128
-
6
Leucht S, Kissling W, Busch R.
Early prediction of non-response – when should antipsychotic drugs be switched?.
Pharmacopsychiatry.
2007;
40
205-255
-
7
Petitclerc M, Bedard PJ, Di Paolo T.
Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study.
Prog Neuropsychopharmacol Biol Psychiatry.
1995;
19
491-497
-
8
Ritsner M, Maayan R, Gibel A, Weizman A.
Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.
Eur Neuropsychopharmacol.
2007;
17
358-365
-
9
Ugale RR, Hirani K, Morelli M, Chopde CT.
Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
Neuropsychopharmacology.
2004;
29
1597-1609
Notice:
This article was changed according to the following erratum on June 22nd 2011.
Erratum:
The correct affiliations of D. Piomelli are:
Departments of Pharmacology and Biological Chemistry, University of California, Irvine, Irvine, CA, USA and Unit of Drug Discovery and Development, Italian Institute of Technology, Genoa, Italy
Correspondence
D. KoetheMD
Department of Psychiatry and Psychotherapy
University of Cologne
Kerpener Str. 62
50924 Cologne
Germany
Phone: +49/221/478 86 231
Fax: +49/221/478 87 200
Email: koethe@ecnp.net
